Co-Authors
This is a "connection" page, showing publications co-authored by Alessandro Rambaldi and Andrea Gianatti.
Connection Strength
0.642
-
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab. Immunobiology. 2020 11; 225(6):152001.
Score: 0.224
-
Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy. Oncotarget. 2018 Feb 09; 9(11):9766-9775.
Score: 0.187
-
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study. BMC Pulm Med. 2021 Mar 20; 21(1):96.
Score: 0.058
-
Bergamo and Covid-19: How the Dark Can Turn to Light. Front Med (Lausanne). 2021; 8:609440.
Score: 0.058
-
At the peak of COVID-19 age and disease severity but not comorbidities are predictors of mortality: COVID-19 burden in Bergamo, Italy. Panminerva Med. 2021 Mar; 63(1):51-61.
Score: 0.057
-
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat Immunol. 2021 01; 22(1):19-24.
Score: 0.057